Advanced search
Start date
Betweenand
Related content

ACYL-HYDRAZONE AND OXADIAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND USES THEREOF

OfficeJPO
Document type:Patent
Inventor(s): Ricardo José Nunes; Alessandra Mascarello; Rosendo Augusto Yunes; Taisa Regina Stumpf; Paulo Cesar Leal; José Andres Yunes; Carolina Pereira De Souza Melo; Rafael Renatino Canevarolo; Louise Domeneghini Chiaradia; André Bortolini Silveira; Anqelo Brunelli Albertoni Laranjeira
Abstract

The present invention relates to acyl-hydrazones derived from 3,4,5-trimethoxyphenylhydrazide for treating diseases associated with cell proliferation (eg, leukemia, tumors, inflammation and other proliferative diseases). The purpose is to provide. The present invention relates to acyl-hydrazone compounds, particularly for cell proliferation such as 3,4,5-trimethoxyphenyl-hydrazide derivatives, and their oxadiazole analogs and other similar compounds, and leukemias. These pharmaceutical uses for treating various related diseases such as acute lymphoblastic leukemia (ALL), tumors and inflammation are provided.


FAPESP's process: 09/04167-1 - Metabolomics of methotrexate resistance in acute lymphoblastic leukemia
Grantee:Rafael Renatino Canevarolo
Principal Investigator:José Andrés Yunes
Institution: Centro Infantil de Investigações Hematológicas Dr Domingos A Boldrini (CIB)
Support Opportunities: Scholarships in Brazil - Master

FAPESP's process: 12/11952-0 - Methotrexate resistance is directly associated with glutathione concentration in acute lymphoblastic leukemia cell lines
Grantee:Rafael Renatino Canevarolo
Principal Investigator:José Andrés Yunes
Institution: Centro Infantil de Investigações Hematológicas Dr Domingos A Boldrini (CIB)
Support Opportunities: Scholarships in Brazil - Doctorate

FAPESP's process: 08/02106-2 - IGFBP7 role in chemotherapy resistance of Pediatric Acute Lymphoblastic Leukemia
Grantee:Angelo Brunelli Albertoni Laranjeira
Principal Investigator:José Andrés Yunes
Institution: Centro Infantil de Investigações Hematológicas Dr Domingos A Boldrini (CIB)
Support Opportunities: Scholarships in Brazil - Doctorate

FAPESP's process: 12/03039-2 - IGFBP7 and insulin/IGFs in Childhood Acute Lymphoblastic Leukemia chemoresistance
Grantee:Angelo Brunelli Albertoni Laranjeira
Principal Investigator:José Andrés Yunes
Institution: Centro Infantil de Investigações Hematológicas Dr Domingos A Boldrini (CIB)
Support Opportunities: Scholarships in Brazil - Post-Doctoral

FAPESP's process: 14/08247-8 - Preclinical studies of novel inhibitors of DNA methyltransferase in acute leukemia
Grantee:Nathalia Moreno Cury
Principal Investigator:José Andrés Yunes
Institution: Centro Infantil de Investigações Hematológicas Dr Domingos A Boldrini (CIB)
Support Opportunities: Scholarships in Brazil - Doctorate